Cite
HARVARD Citation
Csizmarik, A. et al. (2022). Proteome profiling of enzalutamide‐resistant cell lines and serum analysis identified ALCAM as marker of resistance in castration‐resistant prostate cancer. International journal of cancer. 151 (8), pp. 1405-1419. [Online].